| Rachel Morris, | |
|
7119 Gondola Dr, Belle Isle, FL 32809-6809 | |
| (321) 480-1714 | |
| Not Available |
| Full Name | Rachel Morris |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Emergency |
| Location | 7119 Gondola Dr, Belle Isle, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053843904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WE0003X | Registered Nurse - Emergency | RN 9326652 (Florida) | Primary |
| Entity Name | Florida Emergency Physicians Kang And Associates Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811983752 PECOS PAC ID: 0143113878 Enrollment ID: O20040205000687 |
News Archive
Teleflex Incorporated today announced that it has received approval of a significant number of additional certificates to foreign governments ("CFG") from the FDA, totaling forty-one approvals out of eighty-five submitted requests.
Circassia Ltd, a specialty biopharmaceutical company focused on developing world-class immunotherapies, today announced successful results from a large phase II clinical study of its ToleroMune® grass allergy treatment (Grass-Synthetic Peptide Immuno-Regulatory Epitope [Grass-SPIRE])
A biomedical scientist at Ryerson University in Toronto, Canada is exploring how ultrasound and light can be used to measure the effectiveness of cancer treatment in the early stages of therapy. By comparing high-frequency ultrasound patterns before and after treatment, doctors can potentially know within days if a tumor is responding to a prescribed therapy.
Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.
Small amounts of artificial vanilla extract, also known as vanillin, are in a wide range of products, from baked goods to perfumes.
› Verified 7 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20180208000317 |
News Archive
Teleflex Incorporated today announced that it has received approval of a significant number of additional certificates to foreign governments ("CFG") from the FDA, totaling forty-one approvals out of eighty-five submitted requests.
Circassia Ltd, a specialty biopharmaceutical company focused on developing world-class immunotherapies, today announced successful results from a large phase II clinical study of its ToleroMune® grass allergy treatment (Grass-Synthetic Peptide Immuno-Regulatory Epitope [Grass-SPIRE])
A biomedical scientist at Ryerson University in Toronto, Canada is exploring how ultrasound and light can be used to measure the effectiveness of cancer treatment in the early stages of therapy. By comparing high-frequency ultrasound patterns before and after treatment, doctors can potentially know within days if a tumor is responding to a prescribed therapy.
Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.
Small amounts of artificial vanilla extract, also known as vanillin, are in a wide range of products, from baked goods to perfumes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Morris, 7119 Gondola Dr, Belle Isle, FL 32809-6809 Ph: (321) 480-1714 | Rachel Morris, 7119 Gondola Dr, Belle Isle, FL 32809-6809 Ph: (321) 480-1714 |
News Archive
Teleflex Incorporated today announced that it has received approval of a significant number of additional certificates to foreign governments ("CFG") from the FDA, totaling forty-one approvals out of eighty-five submitted requests.
Circassia Ltd, a specialty biopharmaceutical company focused on developing world-class immunotherapies, today announced successful results from a large phase II clinical study of its ToleroMune® grass allergy treatment (Grass-Synthetic Peptide Immuno-Regulatory Epitope [Grass-SPIRE])
A biomedical scientist at Ryerson University in Toronto, Canada is exploring how ultrasound and light can be used to measure the effectiveness of cancer treatment in the early stages of therapy. By comparing high-frequency ultrasound patterns before and after treatment, doctors can potentially know within days if a tumor is responding to a prescribed therapy.
Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.
Small amounts of artificial vanilla extract, also known as vanillin, are in a wide range of products, from baked goods to perfumes.
› Verified 7 days ago
Mrs. Kristy L. Warren, MSN-ED,RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6650 Franconia Dr, Belle Isle, FL 32812 Phone: 321-945-7476 | |
Mary Jean Hyde White, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5440 Chiswick Cir, Belle Isle, FL 32812 Phone: 407-300-7152 |